Authors: YAKHYAEV A MIKHAILENKO I STRICKLAND D SAENKO E

Citation: A. Yakhyaev et al., CELLULAR UPTAKE AND DEGRADATION OF THE THROMBIN-ACTIVATED FACTOR-VIIIFRAGMENTS, Blood, 90(10), 1997, pp. 126-126

Authors: GNATENKO D JESTY J HEARING P SAENKO E BAHOU WF

Citation: D. Gnatenko et al., RECOMBINANT ADENOASSOCIATED VIRUS AS A VEHICLE FOR GENE DELIVERY OF HUMAN MUTANT FACTOR-VIII, Blood, 90(10), 1997, pp. 518-518

Authors: MORICHIKA S SHIMA M TANAKA I NAKAI B SUZUKI H NOGAMI K HATO T MCVEY J TUDDENHAM EGD SAENKO E SCANDELLA D YOSHIOKA A

Citation: S. Morichika et al., A CASE OF FACTOR-VIII C2 ANTIGEN-POSITIVE HEMOPHILIA-A WITH INHIBITORRECOGNIZING THE 44KDA AL DOMAIN - IDENTIFICATION OF A LARGE DELETION FROM EXON-4 TO EXON-7, Blood, 88(10), 1996, pp. 2616-2616

Authors: SCANDELLA D GILBERT GE SHIMA M NAKAI H EAGLESON C FELCH M PRESCOTT R RAJALAKSHMI KJ HOYER LW SAENKO E

Citation: D. Scandella et al., SOME FACTOR-VIII INHIBITOR ANTIBODIES RECOGNIZE A COMMON EPITOPE CORRESPONDING TO C2 DOMAIN AMINO-ACIDS-2248 THROUGH AMINO-ACIDS-2312, WHICH OVERLAP A PHOSPHOLIPID-BINDING SITE, Blood, 86(5), 1995, pp. 1811-1819

Authors: NAKAI H MONDORF W SAENKO E SCANDELLA D

Citation: H. Nakai et al., THE PRESENCE OF ANTI-A1 AND ANTI-B DOMAIN ANTIBODIES IN FACTOR-VIII INHIBITOR PATIENTS, Blood, 86(10), 1995, pp. 746-746